Schiff Hardin recently announced that David H. Resnicoff has joined the firm’s Chicago office as a partner in its litigation group. His practice focuses on internal and government investigations and compliance counseling, with an emphasis on FCPA and healthcare fraud issues. He joins the firm from Miller & Chevalier, where he was a member. For insight from Resnicoff, see “‘No Money, No Prescription’ Attitude in China Leads Bristol-Myers Squibb to $14 Million SEC Penalty” (Oct. 7, 2015); and “Top DOJ and SEC Officials Discuss FCPA Enforcement Priorities and Mechanics” (Apr. 2, 2014).
-
- |
